PHLT (Performant Healthcare) Research & Development: $0.0 Mil (TTM As of Jun. 2025)


PHLT Performant Healthcare Inc PHLT
9 GF Score
Price $7.75
GF Value $3.24
! 4 Warning Signs
View Full Analysis

What is Performant Healthcare Research & Development?

Performant Healthcare PHLT 9 Research & Development is $0.0 Mil as of Jun. 2025. GuruFocus rates PHLT with a GF Score™ of 9/100 and a GF Value™ of $3.24. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Performant Healthcare's Research & Development for the three months ended in Jun. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was $0.0 Mil.

Performant Healthcare  (NAS:PHLT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Performant Healthcare Research & Development Related Terms

Performant Healthcare Research & Development Historical Data

* Premium members only.

The historical data trend for Performant Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Performant Healthcare Research & Development Chart

Performant Healthcare Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Performant Healthcare Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PHLT
9GF Score
Performant Healthcare Inc PHLT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Performant Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Performant Healthcare (PHLT) has a Research & Development of $0.0 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Performant Healthcare and its competitors.
Is Performant Healthcare's Research & Development too high?
Performant Healthcare's current Research & Development is $0.0 Mil. Overall, Performant Healthcare has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Performant Healthcare's Research & Development compare to WEAV and HSTM?
Performant Healthcare's Research & Development of $0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Performant Healthcare and its competitors. Performant Healthcare's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Performant Healthcare stock overvalued right now?
Performant Healthcare (PHLT) has a current Research & Development of $0.0 Mil. The stock's GF Value™ is $3.24, compared to a current price of $7.75 — trading 139.2% above its estimated fair value. The current Research & Development is $0.0 Mil. Performant Healthcare's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Performant Healthcare (PHLT), the current Research & Development is $0.0 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Performant Healthcare (PHLT) Overvalued in 2026?

Based on GuruFocus' analysis, Performant Healthcare stock appears to be overvalued. The current stock price of $7.75 is trading 139.2% above its estimated GF Value™ of $3.24.

Key valuation signals for PHLT:

  • Research & Development: $0.0 Mil
  • GF Value™: $3.24 vs. price of $7.75 (139.2% above fair value)
  • GF Score™: 9/100 with 4 warning signs

No single metric tells the full story. See the PHLT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Performant Healthcare Business Description

Address 900 South Pine Island Road, Suite 150, Plantation, FL, USA, 33324
Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.
9GF Score

Get the complete analysis for PHLT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.75
Price
$3.24
GF Value